Impact of early PCSK9 inhibitor treatment on heart after percutaneous coronary intervention in patients with STEMI: Design and rationale of the PERFECT II trial

Overview of attention for article published in Frontiers in Cardiovascular Medicine, September 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 20,032 followers.

RT @jpcostabel: PCK9 inhibitors in patient with STEMI. this trial will evaluate benefits of early treatment in terms of Myocardial dama ge……

RT @jpcostabel: PCK9 inhibitors in patient with STEMI. this trial will evaluate benefits of early treatment in terms of Myocardial dama ge……

RT @jpcostabel: PCK9 inhibitors in patient with STEMI. this trial will evaluate benefits of early treatment in terms of Myocardial dama ge……

RT @jpcostabel: PCK9 inhibitors in patient with STEMI. this trial will evaluate benefits of early treatment in terms of Myocardial dama ge……

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.